• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Martindale Pharma - Articles and news items

Martindale’s epilepsy oral suspension product approved in 7 European countries

Industry news / 27 October 2016 / Niamh Louise Marriott, Digital Content Producer

Clobazam oral suspension is used principally as an adjunctive therapy for epilepsy with the formulation particularly suitable for children and young adults…

Martindale expands hospital-initiated medicines portfolio through Viridian acquisition

Industry news / 11 July 2016 / Victoria White, Digital Content Producer

Viridian Pharma has developed five products that have regulatory approval in the UK and represent first-to-market specialty hospital-prescribed medicines…

Prenoxad Injection approved in five European countries

Industry news / 12 May 2016 / Victoria White, Digital Content Producer

Prenoxad Injection has been approved in Sweden, Denmark, Ireland, Finland and Estonia following the successful completion of a DCP…

Martindale Pharma expands into Saudi Arabia

Industry news / 1 October 2015 / Victoria White

The company has opened a Scientific Office in Saudi Arabia and has appointed Dr Fahad Al Showaier as Scientific Office Manager…

Martindale Pharma expands international business in Asia Pacific

Industry news / 30 April 2015 / Victoria White

Martindale Pharma today announced the appointment of AFT Pharmaceuticals as its distribution partner for several Asia Pacific markets…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +